Key result
Enhanced external counterpulsation significantly reduced the lung/heart ratio at stress from 0.40 at baseline to 0.35 at 1 month (p=0.001) and 0.33 at 6 months (p=0.03).
Why the study?
Does enhanced external counterpulsation (EECP) improve objective parameters of left ventricular function in patients with coronary artery disease and stress-induced myocardial ischemia?
Population
10 patients with coronary artery disease who showed evidence of stress-induced myocardial ischemia despite…
Design
Case_series
Follow-up
6 months
Authors
Loading...
May support EECP for LV function in refractory CAD ischemia; hypothesis-generating, requires RCTs before practice change.
Observational (n=10)
Does enhanced external counterpulsation (EECP) improve objective parameters of left ventricular function in patients with coronary artery disease and stress-induced myocardial ischemia?
Absolute Event Rate: 0.35% vs 0.4%
p-value: p=0.001
EECP therapy significantly reduced the lung/heart ratio at stress in patients with coronary artery disease and refractory ischemia, suggesting an improvement in left ventricular function.
Wu et al. (2006) conducted an observational in Coronary artery disease (n=10). Enhanced external counterpulsation (EECP) vs. Baseline was evaluated on Lung/heart ratio at stress at 1 month (p=0.001). Enhanced external counterpulsation significantly reduced the lung/heart ratio at stress from 0.40 at baseline to 0.35 at 1 month (p=0.001) and 0.33 at 6 months (p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: